[Tolerance and contrast density in intravenous cholangiography and cholecystography using a new contrast medium (author's transl)].
The tolerance and diagnostic usefulness of the new intravenous bile contrast medium Endomirabil were subjected to clinical radiological testing. Endomirabil is well tolerated. It is our impression that it has a lower side effect quota than the other contrast media used so far. Diagnostic results in injection cholangiography and cholecystography with 30 ml Endomirabil were good. In more than 80% of the cases the bile ducts were well demonstrated. The diagnostic evaluation was fully satisfactory. In most cases both the bile ducts and the gallbladder showed up very well within 60 minutes after completion of the injection. This means both film material and time are saved.
D000328:Adult; D000368:Aged; D002758:Cholangiography / Q000379:methods*; D005260:Female; D006801:Humans; D007463:Iodobenzoates; D008297:Male; D008536:Meglumine / Q000009:adverse effects; D008875:Middle Aged; D013012:Sorbitol / Q000031:analogs & derivatives*; D014283:Triiodobenzoic Acids / Q000009:adverse effects
D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D013012:Sorbitol; D008536:Meglumine
Verträglichkeit und Kontrastdichte bei der intravenösen Cholegraphie mit einem neuen Kontrastmittel.